|
1
|
Renner W and Pilger E: Simultaneous in
vitro quantitation factors of vascular endothelial growth factor
mRNA splice variants. J Vasc Res. 36:133–138. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gargett CE and Rogers PA: Human
endometrial angiogenesis. Reproduction. 121:181–186. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tischer E, Mitchell R, Harrman T, Silva M,
Gospodarowicz D, Fiddes JC and Abraham JA: The human gene for
vascular endothelial growth factor. Multiple protein forms are
encoded through alternative exon splicing. J Biol Chem.
266:11947–11954. 1991.PubMed/NCBI
|
|
4
|
Minchenko A, Bauer T, Salceda S and Caro
J: Hypoxic stimulation of vascular endothelial expression in vitro
and in vivo. Lab Invest. 71:374–379. 1994.PubMed/NCBI
|
|
5
|
Shahbazi M, Fryer AA, Pravica V, Brogan
IJ, Ramsay HM, Hutchinson IV and Harden PN: Vascular endothelial
growth factor gene polymorphisms are associated with acute renal
allograft rejection. J Am Soc Nephrol. 13:260–264. 2002.PubMed/NCBI
|
|
6
|
Steffensen KD, Waldstrøm M, Brandslund I
and Jakobsen A: The relationship of VEGF polymorphisms with serum
VEGF levels and progression-free survival in patients with
epithelial ovarian cancer. Gynecol Oncol. 117:109–116. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Watson CJ, Webb NJ, Bottomley MJ and
Brenchley PE: Identification of polymorphisms within the vascular
endothelial growth factor gene: Correlation with variation in VEGF
protein production. Cytokine. 12:1232–1235. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Renner W, Kotschan S, Hoffmann C,
Obermayer-Pietsch B and Pilger EA: Common 936 C/T mutation in the
gene for vascular endothelial growth factor is associated with
vascular endothelial growth factor plasma levels. J Vasc Res.
37:443–448. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Krippl P, Langsenlehner U, Renner W,
Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J and
Samonigg H: A common 936 C/T gene polymorphisms of vascular
endothelial growth factor is associated with decreased breast
cancer risk. Int J Cancer. 106:468–471. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Grundy SM, Cleeman JI, Daniels SR, Donato
KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith
SC Jr, et al: Diagnosis and management of the metabolic syndrome.
An American Heart Association/National Heart, Lung and Blood
Institute Scientific Statement. Circulation. 112:2735–2752. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Janghorbani M and Amini M: Associations of
hip circumference and height with incidence of type 2 diabetes: The
Isfahan diabetes prevention study. Acta Diabetol. 49:(Suppl 1).
S107–S114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wannamethee SG, Shaper AG, Lennon L and
Morris RW: Metabolic syndrome vs Framingham Risk Score for
prediction of coronary heart disease, stroke, and type 2 diabetes
mellitus. Arch Intern Med. 165:2644–2650. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ervin RB: Prevalence of metabolic syndrome
among adults 20 years of age and over, by sex, age, race and
ethnicity, and body mass index: United States, 2003–2006. Natl
Health Stat Report. 13:1–7. 2009.
|
|
14
|
Barylski M, Kowalczyk E, Banach M,
Ciecwierz J, Pawlicki L and Kowalski J: Plasma total antioxidant
activity in comparison with plasma NO and VEGF levels in patients
with metabolic syndrome. Angiology. 60:87–92. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siervo M, Ruggiero D, Sorice R, Nutile T,
Aversano M, Stephan BC and Ciullo M: Angiogenesis and biomarkers of
cardiovascular risk in adults with metabolic syndrome. J Intern
Med. 268:338–347. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Siervo M, Ruggiero D, Sorice R, Nutile T,
Aversano M, Iafusco M, Vetrano F, Wells JC, Stephan BC and Ciullo
M: Body mass index is directly associated with biomarkers of
angiogenesis and inflammation in children and adolescents.
Nutrition. 28:262–266. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim YR and Hong SH: Association between
the polymorphisms of the vascular endothelial growth factor gene
and metabolic syndrome. Biomed Rep. 3:319–326. 2015.PubMed/NCBI
|
|
18
|
Park YS, Jeon YJ, Kim HS, Chae KY, Oh SH,
Han IB, Kim HS, Kim WC, Kim OJ, Kim TG, et al: The role of VEGF and
KDR polymorphisms in moyamoya disease and collateral
revascularization. PLoS One. 7:e471582012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fernández-Santiago R, Sharma M, Mueller
JC, Gohlke H, Illig T, Anneser J, Münch C, Ludolph A, Kamm C and
Gasser T: Possible gender-dependent association of vascular
endothelial growth factor (VEGF) gene and ALS. Neurology.
66:1929–1931. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang B, Cross DF, Ollerenshaw M, Millward
BA and Demaine AG: Polymorphisms of the vascular endothelial growth
factor and susceptibility to diabetic microvascular complications
in patients with type 1 diabetes mellitus. J Diabetes
Complications. 17:1–6. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu Q, Li Y, Zhao J, Sun DL, Duan YN, Wang
N, Zhou RM and Kang S: Association of polymorphisms −1154G/A and
−2578C/A in the vascular endothelial growth factor gene with
decreased risk of endometriosis in Chinese women. Hum Reprod.
24:2660–2666. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Maltese P, Canestrari E, Ruzzo A, Graziano
F, Falcone A, Loupakis F, Tonini G, Santini D and Magnani M: VEGF
gene polymorphisms and susceptibility to colorectal cancer disease
in Italian population. Int J Colorectal Dis. 24:165–170. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Howell WM, Ali S, Rose-Zerilli MJ and Ye
S: VEGF polymorphisms and severity of atherosclerosis. J Med Genet.
42:485–490. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jeon YJ, Kim JH, Rah H, Kim SY, Yoon TK,
Choi DH, Cha SH, Shim SH and Kim NK: Vascular endothelial growth
factor gene polymorphisms in spontaneously aborted fetuses. Am J
Reprod Immunol. 66:544–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McCarron SL, Edwards S, Evans PR, Gibbs R,
Dearnaley DP, Dowe A, Southgate C, Easton DF, Eeles RA and Howell
WM: Influence of cytokine gene polymorphisms on the development of
prostate cancer. Cancer Res. 62:3369–3372. 2002.PubMed/NCBI
|
|
26
|
Howell WM, Bateman AC, Tumer SJ, Collins A
and Theaker JM: Influence of vascular endothelial growth factor
single nucleotide polymorphisms on tumour development in cutaneous
malignant melanoms. Genes Immun. 3:229–232. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Papazoglou D, Galazios G, Papatheodorou K,
Liberis V, Papanas N, Maltezos E and Maroulis GB: Vascular
endothelial growth factor gene polymorphisms and idiopathic
recurrent pregnancy loss. Fertil Sterril. 83:959–963. 2005.
View Article : Google Scholar
|
|
28
|
Hefler LA, Mustea A, Könsgen D, Concin N,
Tanner B, Strick R, Heinze G, Grimm C, Schuster E, Tempfer C, et
al: Vascular endothelial growth factor gene polymorphisms are
associated with prognosis in ovarian cancer. Clin Cancer Res.
13:898–901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schneider BP, Radovich M, Sledge GW,
Robarge JD, Li L, Storniolo AM, Lemler S, Nguyen AT, Hancock BA,
Stout M, et al: Association of polymorphisms of angiogenesis genes
with breast cancer. Breast Cancer Res Treat. 111:157–163. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sfar S, Saad H, Mosbah F and Chouchane L:
Combined effects of the angiogenic genes polymorphisms on prostate
cancer susceptibility and aggressiveness. Mol Biol Rep. 36:37–45.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Koukourakis MI, Papazoglou D,
Giatromanolaki A, Bougioukas G, Maltezos E and Sivridis E: VEGF
gene sequence variation defines VEGF gene expression status and
angiogenic activity in non-small cell lung cancer. Lung Cancer.
46:293–298. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lambrechts D, Storkebaum E, Morimoto M,
Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J,
van Marion I, et al: VEGF is a modifier of amyotrophic lateral
sclerosis in mice and humans and protects motoneurons against
ischemic death. Nat Genet. 34:383–394. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fu Y, Ni P, Ma J, Ying Y, Zhao J, Liu J
and Chen S: Polymorphisms of human vascular endothelial growth
factor gene are associated with acute cerebral infarction in the
Chinese population. Eur Neurol. 66:47–52. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Park HM, Hong SH, Kim JW, Oh D, Hwang SG,
An HJ, An HJ, Kim UK and Kim NK: Gender-specific association of the
VEGF −2578C>A polymorphism in Korean patients with colon cancer.
Anticancer Res. 27:2535–2539. 2007.PubMed/NCBI
|
|
35
|
Muniz JJ, Izidoro-Toledo TC, Metzger IF,
Sandrim VC and Tanus-Santos JE: Interethnic differences in the
distribution of clinically relevant vascular endothelial growth
factor genetic polymorphisms. DNA Cell Biol. 28:567–572. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee HH, Hong SH, Shin SJ, Ko JJ, Oh D and
Kim NK: Association study of vascular endothelial growth factor
polymorphisms with the risk of recurrent spontaneous abortion.
Fertil Steril. 93:1244–1247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Choi YS, Choi JK, Kim JW, Min KT, Kwon YD,
Jang MJ, Chong SY, Oh D, Cho YK, Hong SH and Kim NK: Association of
the vascular endothelial growth factor (VEGF −1154G>A)
polymorphism in patients with colorectal cancer. Genes Genomics.
33:133–138. 2011. View Article : Google Scholar
|
